These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Temporally controlled multiple-gene delivery in scaffolds: A promising strategy to enhance bone regeneration. Liu J; Xu L; Li Y; Ma J Med Hypotheses; 2011 Feb; 76(2):173-5. PubMed ID: 20926199 [TBL] [Abstract][Full Text] [Related]
9. Growth factor delivery for bone tissue repair: an update. Varkey M; Gittens SA; Uludag H Expert Opin Drug Deliv; 2004 Nov; 1(1):19-36. PubMed ID: 16296718 [TBL] [Abstract][Full Text] [Related]
10. Bone regeneration with active angiogenesis by basic fibroblast growth factor gene transfected mesenchymal stem cells seeded on porous beta-TCP ceramic scaffolds. Guo X; Zheng Q; Kulbatski I; Yuan Q; Yang S; Shao Z; Wang H; Xiao B; Pan Z; Tang S Biomed Mater; 2006 Sep; 1(3):93-9. PubMed ID: 18458388 [TBL] [Abstract][Full Text] [Related]
11. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. Zhao M; Zhao Z; Koh JT; Jin T; Franceschi RT J Cell Biochem; 2005 May; 95(1):1-16. PubMed ID: 15759283 [TBL] [Abstract][Full Text] [Related]
12. Scaffold-based bone engineering by using genetically modified cells. Hutmacher DW; Garcia AJ Gene; 2005 Feb; 347(1):1-10. PubMed ID: 15777645 [TBL] [Abstract][Full Text] [Related]
13. Viral vectors for gene delivery in tissue engineering. Zhang X; Godbey WT Adv Drug Deliv Rev; 2006 Jul; 58(4):515-34. PubMed ID: 16762441 [TBL] [Abstract][Full Text] [Related]
14. Tissue engineering by modulated gene delivery. Yamamoto M; Tabata Y Adv Drug Deliv Rev; 2006 Jul; 58(4):535-54. PubMed ID: 16762442 [TBL] [Abstract][Full Text] [Related]
15. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149 [TBL] [Abstract][Full Text] [Related]
16. Engineering osteogenesis and chondrogenesis with gene-enhanced therapeutic cells. Hao J; Varshney RR; Wang DA Curr Opin Mol Ther; 2009 Aug; 11(4):404-10. PubMed ID: 19649985 [TBL] [Abstract][Full Text] [Related]
18. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection. Douglas KL Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953 [TBL] [Abstract][Full Text] [Related]
19. [Application of gene therapy mediated by adenovirus vectors for bone trauma and bone disease]. Liu JZ; Ji ZL; Hu YY Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 May; 17(3):215-8. PubMed ID: 12822354 [TBL] [Abstract][Full Text] [Related]
20. Current concepts in gene therapy of the musculoskeletal system. Ivković A; Pascher A; Hudetz D; Jelić M; Haspl M; Windhager R; Pećina M Acta Chir Orthop Traumatol Cech; 2006 Apr; 73(2):115-22. PubMed ID: 16735009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]